Authors
Latest:
Taxing Times for French PharmaWhile French politics has taken a decisive shift to the left with the election of the country’s first socialist president for 17 years
Latest:
Under InvestigationI thought I knew all of the definitions for healthcare compliance when I left my job at a traditional pharma company in 1998 to become chief operating officer of a company that sold both medical diagnostics products and pharmaceuticals.
Latest:
Three Challenges to CRO SuccessThe last few years have seen tremendous consolidation in both the pharmaceutical and contract research industries. The impact among pharma companies has created a heightened demand for productivity. Consequently, contract research organizations (CROs) have struggled to find their footing in a business where the number of customers has shrunk and the demand for speed and cost-effectiveness has risen. Delivering service excellence when customers' names and addresses are changing regularly is a challenge, resulting in disrupted continuity, broken lines of communication, and policies and relationships thrown into disarray.
Latest:
The Need for Intelligent IP managementSimon Webster looks at the role of intellectual property (IP) management in protecting pharmaceutical company products.
Latest:
Pairing UpMarket researchers often fail to realize that whenever they collect competitor information they are in fact collecting competitive intelligence. The same is true in reverse.
Latest:
Tools Are Just the BeginningPharma companies are committed to using electronic data capture in clinical trials. Technology adoption will continue to grow, as FDA and consumers want faster safety data.
Latest:
The evolution of the pharmaceutical sales representativeHow the job has changed over the years.
Latest:
ISPOR Task Force Grapples with Value QuestionsISPOR's Value Assessment Stakeholder Conference showed its Special Task Force still reaching for clarification around the subject, writes Ansis Helmanis.
Latest:
Syncing Personalized Medicine and MarketingThe age of genomics is giving rise to highly specialized diagnostic tools, targeted therapies, and personalized drug monitoring. This new generation of individualized treatments will require life sciences companies to evolve how they reach and educate the healthcare community. Are your commercial operations up to the task?
Latest:
Is access possible in tough markets?In the 1990s, the promise of healthcare reform and the rise of managed care created unique markets, where the business of selling pharmaceuticals has been at the mercy of often unknown pressures. These market fluctuations have created physician access trouble for the pharmaceutical industry, and tricks of the trade no longer get reps through the door.
Latest:
Meeting the Physician Spend Management ChallengeRavi Shankar asks how pharmaceutical firms can best organise the vast amounts of data needed to stay in compliance with issues such as physician spend management.
Latest:
The New Hot Topics in Supply Chain ManagementTimes are changing in the pharmaceutical and life sciences sectors and their supply chains are having to adapt to a new set of challenges, says Kenneth Porter of specialist consultancy Total Logistics.
Latest:
Lean Comes to PharmaThe business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?
Latest:
The 3Cs of Successful Outsourcing:Communicate, Collaborate, CapitalizeIn a volatile and highly competitive market, one way for pharma companies to keep an edge is through better communication. Companies routinely outsource the services and processes involved in the formulation, manufacture, packaging, labeling, and delivery of products. Leveraging the resources of third parties can be both cost-effective and efficient. But not all companies successfully communicate and collaborate with their partners to capitalize on those benefits.
Latest:
2010 Products and Therapy Areas to WatchThomson Reuters' global pharma forecast for next year.
Latest:
Reimbursement: The foundation for financial decisionsIn our quest as sales reps to provide our physician customers with a valuable sales call, it is crucial to understand what the driving forces are in healthcare delivery and how they affect these customers.
Latest:
Lean Comes to PharmaThe business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?
Latest:
One World, Many RegulationsThe ability to compete globally is essential to success in the pharmaceutical industry. The current trend is to establish joint ventures, outsource various stages of the development and production of a single pharma product, and purchase or start an indigenous business in other countries.
Latest:
Lean Comes to PharmaThe business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?
Latest:
European Pricing Talks: A lot of Smoke—or is it Fire?What to make of the simmering public and political angst
Latest:
We Need to Rock the Boat to Make Research SoarWe hear it all the time these days: research processes have to undergo transformative changes in order for research organizations to thrive-or even survive. Controlled clinical trials take too long and cost too much. Regulatory review is blocking innovation.
Latest:
Optimal Pricing StrategiesPricing has never been more of a key issue for the industry than it is right now. Yet, even with the increased importance of pricing strategies, a lack of focus on critical market factors leads many manufacturers to forego profits or increase their vulnerability to aggressive payers. Aligning pricing and contracting can achieve a sustainable competitive advantage-if product managers objectively assess a product's clinical benefits and address two key questions:
Latest:
The New Four P's of MarketingThe rules of the game have changed. While pharmaceutical executives have been busy trying to keep up with a radically shifting marketing landscape, technology has swept in and changed everything marketers held sacred.
Latest:
Sidewiki: What's Pharma to Do?Google opened up a whole new era of social media when it released Sidewiki - a tool that allows anyone to comment on any Web site. Now pharma has a new battle to fight.
